Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 30:10:1234271.
doi: 10.3389/fcvm.2023.1234271. eCollection 2023.

Unraveling the role of VLDL in the relationship between type 2 diabetes and coronary atherosclerosis: a Mendelian randomization analysis

Wenshuai Feng  1 , Liuli Guo  1 , Yiman Liu  1 , Ming Ren  2
Affiliations

Unraveling the role of VLDL in the relationship between type 2 diabetes and coronary atherosclerosis: a Mendelian randomization analysis

Wenshuai Feng et al. Front Cardiovasc Med. .

Abstract

Background: The causal link between Type 2 diabetes (T2D) and coronary atherosclerosis has been established through wet lab experiments; however, its analysis with Genome-wide association studies (GWAS) data remains unexplored. This study aims to validate this relationship using Mendelian randomization analysis and explore the potential mediation of VLDL in this mechanism.

Methods: Employing Mendelian randomization analysis, we investigated the causal connection between T2D and coronary atherosclerosis. We utilized GWAS summary statistics from European ancestry cohorts, comprising 23,363 coronary atherosclerosis patients and 195,429 controls, along with 32,469 T2D patients and 183,185 controls. VLDL levels, linked to SNPs, were considered as a potential mediating causal factor that might contribute to coronary atherosclerosis in the presence of T2D. We employed the inverse variance weighted (IVW), Egger regression (MR-Egger), weighted median, and weighted model methods for causal effect estimation. A leave-one-out sensitivity analysis was conducted to ensure robustness.

Results: Our Mendelian randomization analysis demonstrated a genetic association between T2D and an increased coronary atherosclerosis risk, with the IVW estimate at 1.13 [95% confidence interval (CI): 1.07-1.20]. Additionally, we observed a suggestive causal link between T2D and VLDL levels, as evidenced by the IVW estimate of 1.02 (95% CI: 0.98-1.07). Further supporting lipid involvement in coronary atherosclerosis pathogenesis, the IVW-Egger estimate was 1.30 (95% CI: 1.06-1.58).

Conclusion: In conclusion, this study highlights the autonomous contributions of T2D and VLDL levels to coronary atherosclerosis development. T2D is linked to a 13.35% elevated risk of coronary atherosclerosis, and within T2D patients, VLDL concentration rises by 2.49%. Notably, each standard deviation increase in VLDL raises the likelihood of heart disease by 29.6%. This underscores the significant role of lipid regulation, particularly VLDL, as a mediating pathway in coronary atherosclerosis progression.

Keywords: Mendelian randomization; coronary atherosclerosis; mediation pathway; type 2 diabetes; very low-density lipoprotein.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Three assumptions about instrumental variables (IV).
Figure 2
Figure 2
Research flow chart. Adapted from Smart Medical Art (Available at: https://smart.servier.com/).
Figure 3
Figure 3
MR analysis.
Figure 4
Figure 4
Forest plots of MR analysis.
Figure 5
Figure 5
The result of 5 methods and 2 tests.
Figure 6
Figure 6
“leave one out” sensitivity analysis.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Li Y, Guo C, Cao Y. Secular incidence trends and effect of population aging on mortality due to type 1 and type 2 diabetes mellitus in China from 1990 to 2019: findings from the global burden of disease study 2019. BMJ Open Diabetes Res Care. (2021) 9(2):e002529. 10.1136/bmjdrc-2021-002529 - DOI - PMC - PubMed
    1. Yun JS, Ko SH. Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes. Metab Clin Exp. (2021) 123:154838. 10.1016/j.metabol.2021.154838 - DOI - PubMed
    1. Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. (2020) 18(2):117–24. 10.2174/1570161117666190502103733 - DOI - PubMed
    1. Merino J, Jablonski KA, Mercader JM, Kahn SE, Chen L, Harden M, et al. Interaction between type 2 diabetes prevention strategies and genetic determinants of coronary artery disease on cardiometabolic risk factors. Diabetes. (2020) 69(1):112–20. 10.2337/db19-0097 - DOI - PMC - PubMed
    1. Smith GD, Ebrahim S. Data dredging, bias, or confounding: they can all get you into the BMJ and the Friday papers. Br Med J. (2002) 325(7378):1437–8. 10.1136/bmj.325.7378.1437 - DOI - PMC - PubMed